Abstract: During the course of extensive mutagenesis of HLA-A2.1, we examined influenza A
matrix peptide (FMP)-specific CTL recognition of HMy2.
C1R (
C1R) cells expressing mutant HLA-A2.1 molecules, sensitized with synthetic peptide, FMP 58-66, (exogenous peptide), or infected with influenza A virus (endogenous peptide).
Abstract: Pulse-chase analyses followed by endoglycosidase-H treatment show that the rate of maturation and processing of the five mutant HLA-A2 molecules in
C1R cells is identical to that of wild type.
Abstract: The remaining three mutants,
Y27N,
Q32K, and
S132C, fail to present exogenous peptide, but present endogenous peptide to FMP-specific CTL.
Abstract: Two of the five mutants,
F9L an